# A 10-12 Week Study to Evaluate the Safety and Efficacy of 320 mg Valsartan and 80 mg Simvastatin in Combination and as Monotherapies in Treating Hypertension and Hypercholesterolemia

> **NCT00171093** · PHASE3 · COMPLETED · sponsor: **Novartis** · enrollment: 369 (—)

## Conditions studied

- HYPERTENSION
- HYPERCHOLESTEROLEMIA

## Interventions

- **DRUG:** valsartan + simvastatin

## Key facts

- **NCT ID:** NCT00171093
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** 2006-01
- **Final completion:** —
- **Target enrollment:** 369 (—)
- **Last updated:** 2017-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00171093

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00171093, "A 10-12 Week Study to Evaluate the Safety and Efficacy of 320 mg Valsartan and 80 mg Simvastatin in Combination and as Monotherapies in Treating Hypertension and Hypercholesterolemia". Retrieved via MORVS 2026-10-22 from https://api.morvs.ai/clinical/NCT00171093. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*